Tolerance of the normal canine brain to epithermal neutron irradiation in the presence of p-boronophenylalanine

被引:12
作者
Coderre, JA [1 ]
Gavin, PR
Capala, J
Ma, R
Morris, GM
Button, TM
Aziz, T
Peress, NS
机构
[1] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
[2] Washington State Univ, Pullman, WA 99164 USA
[3] Univ Oxford, Churchill Hosp, Res Inst, Oxford, England
[4] SUNY Stony Brook, Sch Med, Dept Pathol, Div Neuropathol, Stony Brook, NY 11794 USA
关键词
boron neutron capture therapy; boronophenylalanine; BNCT; brain; epithermal neutrons; irradiation; normal tissue tolerance;
D O I
10.1023/A:1006419210584
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Twelve normal dogs underwent brain irradiation in a mixed-radiation, mainly epithermal neutron field at the Brookhaven Medical Research Reactor following intravenous infusion of 950 mg of (10)B-enriched BPA/kg as its fructose complex. The 5 x 10 cm irradiation aperture was centered over the left hemisphere. For a subgroup of dogs reported previously, we now present more detailed analyses including dose-volume relationships, longer follow-ups, MRIs, and histopathological observations. Peak doses (delivered to 1 cm(3) of brain at the depth of maximum thermal neutron flux) ranged from 7.6 Gy (photon-equivalent dose: 11.8 Gy-Eq) to 11.6 Gy (17.5 Gy-Eq). The average dose to the brain ranged from 3.0 Gy (4.5 Gy-Eq) to 8.1 Gy (11.9 Gy-Eq) and to the left hemisphere, 6.6 Gy (10.1 Gy-Eq) to 10.0 Gy (15.0 Gy-Eq). Maximum tolerated 'threshold' doses were 6.7 Gy (9.8 Gy-Eq) to the whole brain and 8.2 Gy (12.3 Gy-Eq) to one hemisphere. The threshold peak brain dose was 9.5 Gy (14.3 Gy-Eq). At doses below threshold, some dogs developed subclinical MRI changes. Above threshold, all dogs developed dose-dependent MRI changes, neurological deficits, and focal brain necrosis.
引用
收藏
页码:27 / 40
页数:14
相关论文
共 45 条
[1]   DETERMINATION OF BORON IN TISSUES AND CELLS USING DIRECT-CURRENT PLASMA ATOMIC EMISSION-SPECTROSCOPY [J].
BARTH, RF ;
ADAMS, DM ;
SOLOWAY, AH ;
MECHETNER, EB ;
ALAM, F ;
ANISUZZAMAN, AKM .
ANALYTICAL CHEMISTRY, 1991, 63 (09) :890-893
[2]   Boron neutron capture therapy of brain tumors: Past history, current status, and future potential [J].
Barth, RF ;
Soloway, AH ;
Brugger, RM .
CANCER INVESTIGATION, 1996, 14 (06) :534-550
[3]   Boron neutron capture therapy of brain tumors: An emerging therapeutic modality [J].
Barth, RF ;
Soloway, AH ;
Goodman, JH ;
Gahbauer, RA ;
Gupta, N ;
Blue, TE ;
Yang, WL ;
Tjarks, W .
NEUROSURGERY, 1999, 44 (03) :433-450
[4]  
BAUER WF, 1993, ADVANCES IN NEUTRON CAPTURE THERAPY, P403
[5]  
Bergland R, 1996, CANCER NEUTRON CAPTURE THERAPY, P739
[6]  
BUSSE P, P 8 INT S NEUTR CAPT
[7]   FAST-NEUTRONS COMPARED WITH MEGAVOLTAGE X-RAYS IN THE TREATMENT OF PATIENTS WITH SUPRATENTORIAL GLIOBLASTOMA - A CONTROLLED PILOT-STUDY [J].
CATTERALL, M ;
BLOOM, HJG ;
ASH, DV ;
WALSH, L ;
RICHARDSON, A ;
UTTLEY, D ;
GOWING, NFC ;
LEWIS, P ;
CHAUCER, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (03) :261-266
[8]   Boron neutron capture therapy for glioblastoma multiforme: Interim results from the Phase I/II dose-escalation studies [J].
Chanana, AD ;
Capala, J ;
Chadha, M ;
Coderre, JA ;
Diaz, AZ ;
Elowitz, EH ;
Iwai, J ;
Joel, DD ;
Liu, HGB ;
Ma, RM ;
Pendzick, N ;
Peress, NS ;
Shady, MS ;
Slatkin, DN ;
Tyson, GW ;
Wielopolski, L .
NEUROSURGERY, 1999, 44 (06) :1182-1192
[9]   Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity [J].
Coderre, JA ;
Chanana, AD ;
Joel, DD ;
Elowitz, EH ;
Micca, PL ;
Nawrocky, MM ;
Chadha, M ;
Gebbers, JO ;
Shady, M ;
Peress, NS ;
Slatkin, DN .
RADIATION RESEARCH, 1998, 149 (02) :163-170
[10]   Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results [J].
Coderre, JA ;
Elowitz, EH ;
Chadha, M ;
Bergland, R ;
Capala, J ;
Joel, DD ;
Liu, HYB ;
Slatkin, DN ;
Chanana, AD .
JOURNAL OF NEURO-ONCOLOGY, 1997, 33 (1-2) :141-152